Cite
HARVARD Citation
Greene, J. et al. (n.d.). 2764 Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence. European journal of cancer. pp. S552-. [Online].